Old Economy Sectors Lead While Chips and Biotech Fall Apart
Energy and staples are posting fresh highs as semiconductors and biotech break down hard, a classic defensive rotation as of the October 16 close.
The leaderboard looks nothing like it did a month ago
Money has been quietly leaving the sectors that led the market higher for most of the year and piling into the ones Wall Street usually only loves when it's nervous. That is the story sitting right in the numbers as of the close on October 16, 2026.
1-month leaders:
- XLE (Energy): +5.83%, trend is a clean uptrend, price is just 0.07% off its 52-week high
- XLP (Consumer Staples): +4.95%, uptrend, RSI14 at 71.9 and stretched
- XLV (Health Care): +4.68%, uptrend, RSI14 at 66
- XLB (Materials): +0.41%, pullback within a longer uptrend
- XLY (Consumer Discretionary): +0.96%, but trend flagged as a downtrend below both the 50-day and 200-day
1-month laggards:
- SMH (Semiconductors): -3.71% over the month and -10.53% over just the last 5 days
- XBI (Biotech): -8.80%, pullback within a longer uptrend, RSI14 at 35.9
- GDX (Gold Miners): -8.56%, sideways/mixed despite a 23.99% 3-month gain
- KRE (Regional Banks): -4.03%, sideways/mixed
- XLK (Technology): -2.44% over the month, -7.70% over 5 days
Energy and staples are doing the heavy lifting
XLE closed at 68.24, up 2.52% on the day alone and up 4.86% over 5 days, sitting 7.40% above its 50-day average and 18.44% above its 200-day. RSI14 at 69.1 is firmly in overbought territory, and the sector is trading just a hair under its 52-week high of 68.29. Volume came in at 1.15 times the 20-day average, suggesting real participation behind the move rather than a thin drift higher.
XLP tells a similar story with a twist: it closed at 87.62, up 5.02% over 5 days, with volume running at 1.92 times average, nearly double normal turnover. That kind of volume surge in a defensive sector is worth noting. RSI14 at 71.9 means staples are also overbought, and the sector sits just below resistance at 88.78.
XLV rounds out the defensive triumvirate, up 4.68% over the month and holding a RSI14 of 66. None of these three are cheap by momentum measures right now, but the trend structure (price above a rising 50-day, 50-day above 200-day) is intact for all three.
The breakdown in growth is the real headline
While energy and staples grind higher, the growth and risk-on parts of the market are falling apart fast. SMH lost 10.53% in just 5 days and closed at 539.79, a full 19.65% off its 52-week high. The MACD histogram sits deeply negative at -9.411, and volume came in at 2.39 times the 20-day average on the way down, a sign of real selling pressure, not just quiet drift.
XLK isn't far behind: a 1-day drop of 3.02% and a 5-day decline of 7.70%, with a bearish MACD crossover flagged within the last 5 sessions. RSI14 at 33.3 shows the sector is now oversold after being one of the year's strongest performers. XBI shows the same pattern: down 8.80% over the month, RSI14 at 35.9, and a support level at 143.78 sitting right under Friday's close of 144.32.
What this rotation is telling us
When energy, staples, and health care lead while semiconductors, biotech, and technology break down, that is a textbook defensive rotation. It usually means capital is positioning more cautiously, favoring sectors with steady cash flows and real-world demand (oil, consumer goods, drugs) over higher-beta growth names that had gotten extended. XLY's slip into a confirmed downtrend (below both the 50-day and 200-day) adds to that read, since discretionary spending names tend to lead on the way up and lag on the way down.
Not everything fits neatly into that story. GDX is down 8.56% on the month despite a huge 23.99% 3-month gain, which looks more like a sharp pullback after a parabolic run than a true rotation signal. KRE and XLI are both labeled sideways or mixed, sitting in no-man's land rather than confirming either the risk-on or risk-off camp.
The setup to watch is whether the energy and staples leadership holds once RSI readings above 70 start to cool off, or whether this is simply money parking defensively while the technology and semiconductor names work off an overbought condition that had pushed SMH and XLK well above their 50-day averages earlier this year. A rotation like this either marks genuine caution about growth stocks, or it is a temporary pause before leadership snaps back once the selling in chips and biotech exhausts itself. The next couple of weeks of closes relative to the levels above should make that distinction clearer.

